Recent Insider Transactions - Acrivon Therapeutics (NASDAQ: ACRV)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

05/21/2025

Sell

$1.15

19,904

$23K

2.21M

NASDAQ ACRV Acrivon Therapeutics

Peterson Katharine / officer: Chief Accounting Officer

05/14/2025

Sell

$1.14

$113

4,320

NASDAQ ACRV Acrivon Therapeutics

Miller Mary / officer: Chief Legal Officer

05/14/2025

Sell

$1.14

184

$210

36,323

NASDAQ ACRV Acrivon Therapeutics

Gamelin Erick / officer: Chief Development Officer

05/14/2025

Sell

$1.14

403

$459

16,089

NASDAQ ACRV Acrivon Therapeutics

Devroe Eric / officer: Chief Operating Officer

05/14/2025

Sell

$1.14

613

$699

66,534

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

05/14/2025

Sell

$1.14

59,766

$68K

2.23M

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

05/14/2025

Sell

$1.14

491

$560

315,686

NASDAQ ACRV Acrivon Therapeutics

PERCEPTIVE ADVISORS LLC / 10 percent owner

04/30/2025

Sell

$1.41

437,881

$617K

3.40M

NASDAQ ACRV Acrivon Therapeutics

PERCEPTIVE ADVISORS LLC / 10 percent owner

05/01/2025

Sell

$1.34

298,886

$401K

3.10M

NASDAQ ACRV Acrivon Therapeutics

PERCEPTIVE ADVISORS LLC / 10 percent owner

04/25/2025

Sell

$1.95

1.05M

$2.057M

4.31M

NASDAQ ACRV Acrivon Therapeutics

PERCEPTIVE ADVISORS LLC / 10 percent owner

04/28/2025

Sell

$1.56

215,283

$336K

4.09M

NASDAQ ACRV Acrivon Therapeutics

PERCEPTIVE ADVISORS LLC / 10 percent owner

04/29/2025

Sell

$1.41

250,000

$353K

3.84M

NASDAQ ACRV Acrivon Therapeutics

Miller Mary / officer: Chief Legal Officer

04/17/2025

Sell

$1.81

558

$1K

36,507